Comparative study assessed extraction efficiency of 5-nitroimidazoles in honey, indicating a pressing need for quality control measures.
Abstract The use of 5-nitroimidazoles such as metronidazole, dimetridazole, ronidazole, tinidazole and ipronidazole against Nosema infections raises significant health concerns due to their mutagenic and carcinogenic effects. This study optimized two extraction methods for 5-nitroimidazoles in honey: 52734-U-SupelMIP™ Solid-Phase Extraction and QuEChERS, analyzed by LC-MS/MS technique. The optimized method achieved detection limits of (0.05–0.19 µg/kg) and quantification limits of (0.33–0.46 µg/kg). Linearity was demonstrated (R² > 0.99) over (0.3-3.0 µg/kg), with repeatability < 17.24% RSD and recovery rates of (69.98–102.70)%. 52734-U-SupelMIP™ Solid-Phase Extraction showed 35.35% higher extraction efficiency than QuEChERS extraction method. Analysis of 24 Albanian honey samples revealed residues in 12.5% of samples ([0.59-53.00 µg/kg] range). Three samples exceeded the Minimum Required Performance Limit (MRPL) set by Commission Implementing Regulation (EU) 2021/808 of 1 µg/kg, with maximum levels of (53.00 µg/kg) for metronidazole. These findings highlight the urgent need for rigorous nitroimidazole monitoring in honey to protect bee and human health.
No takes yet. Share an insight, caveat, or question.
Vaso et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: